Evaluating full-body imaging technology for skin disease detection

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical investigation assesses the feasibility of using full-body multi-modal imaging technology for screening and monitoring various skin diseases, including skin cancer and atopic dermatitis. Participants undergo a primary care visit where high-resolution 2D and 3D images, along with thermal images, are captured to evaluate skin lesions. The study aims to correlate these imaging results with clinical diagnoses and improve early detection methods in primary care settings.

Why it matters

Who can join: the full rules

Inclusion criteria:

* Adult patients that are part of the regular healthcare patient flow at the investigational sites, or as separately invited to participate in this investigation.
* Patients with signed informed consent

Exclusion criteria:

* Cognitive impairment
* Patients unable to understand the oral and written study information in Swedish or English
* Other severe disorder or terminal disease
* Patients unable to provide an informed consent
* Patients not able to keep balance, while standing up with closed eyes, without any aid
* Claustrophobic patients

Where it's running

• Atrium Health Care Centre
  Stockholm, Sweden Recruiting
• Neko Health Centre Regeringsgatan
  Stockholm, Sweden Recruiting
• Neko Health Centre Sibyllegatan
  Stockholm, Sweden Recruiting

Study contacts

• Principal investigator: Andreea Valdman, MD — Neko Health AB
• Study coordinator: Mattias Windå, MSc
• Email: mattias@nekohealth.com
• Phone: 0703169040

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Non-invasive imaging to measure skin composition and structure

  This study is testing a new non-invasive imaging technology to see if it can accurately measure different components and structures of skin in people visiting their primary care doctor, especially those at higher risk for heart issues or diabetes.

  Recruiting at 3 sites HJN Sverige AB/Neko Health · Stockholm and 2 other locations · NCT06976073

• PALLAS 311 nm UVB laser treatment for vitiligo, psoriasis, alopecia areata, and atopic dermatitis

  This study will test the PALLAS 311 nm UVB laser as an in-clinic, twice-weekly treatment for adults with vitiligo, psoriasis, alopecia areata, or atopic dermatitis for up to three months.

  Recruiting Szeged University · Szeged, Csongrád-Csanád Vármegye · NCT07250997

• New ceramide‑and‑coconut‑oil skin barrier cream versus petrolatum for dry or irritated skin

  This study will test whether a new ceramide- and coconut oil–based cream can improve skin hydration and reduce dryness and itch in adults with mild to moderate psoriasis, atopic dermatitis, contact dermatitis, or xerosis.

  Recruiting Makati Medical Center · Makati City, National Capital Region · NCT07183423

• Herbal ointment for treating atopic dermatitis

  This study is testing a herbal ointment made from a plant to see if it can help people with atopic dermatitis feel better.

  Recruiting Phase 2/3 En Chu Kong Hospital · New Taipei City · NCT06850311

• Evaluating human placental membrane products for treating nonhealing diabetic foot and venous leg ulcers

  This study is testing whether using human placental products along with regular care can help people with stubborn diabetic foot and leg ulcers heal better.

  Recruiting C5 Biomedical · Metairie, Louisiana · NCT06674980

• Biomarkers that predict how skin-disease treatments will work

  Researchers are testing blood and skin markers to see if they can forecast which patients with inflammatory skin diseases will respond to systemic treatments over a year.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT06599411

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.